Adverum Biotechnologies Inc (ADVM)
8.01
-0.24
(-2.91%)
USD |
NASDAQ |
May 17, 16:00
8.01
0.00 (0.00%)
After-Hours: 20:00
Adverum Biotechnologies Research and Development Expense (Quarterly): 15.41M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.41M |
| December 31, 2023 | 15.28M |
| September 30, 2023 | 20.74M |
| June 30, 2023 | 20.60M |
| March 31, 2023 | 21.06M |
| December 31, 2022 | 22.20M |
| September 30, 2022 | 23.85M |
| June 30, 2022 | 30.26M |
| March 31, 2022 | 22.96M |
| December 31, 2021 | 22.52M |
| September 30, 2021 | 24.07M |
| June 30, 2021 | 22.61M |
| March 31, 2021 | 19.98M |
| December 31, 2020 | 22.73M |
| September 30, 2020 | 16.65M |
| June 30, 2020 | 19.18M |
| March 31, 2020 | 14.75M |
| December 31, 2019 | 11.37M |
| September 30, 2019 | 9.944M |
| June 30, 2019 | 8.97M |
| March 31, 2019 | 10.13M |
| December 31, 2018 | 11.64M |
| September 30, 2018 | 14.48M |
| Date | Value |
|---|---|
| June 30, 2018 | 11.22M |
| March 31, 2018 | 12.79M |
| December 31, 2017 | 12.01M |
| September 30, 2017 | 10.27M |
| June 30, 2017 | 8.492M |
| March 31, 2017 | 9.061M |
| December 31, 2016 | 7.898M |
| September 30, 2016 | 8.362M |
| June 30, 2016 | 7.955M |
| March 31, 2016 | 7.455M |
| December 31, 2015 | 7.192M |
| September 30, 2015 | 7.523M |
| June 30, 2015 | 5.126M |
| March 31, 2015 | 5.621M |
| December 31, 2014 | 7.226M |
| September 30, 2014 | 5.746M |
| June 30, 2014 | 3.094M |
| March 31, 2014 | 0.91M |
| December 31, 2013 | 0.739M |
| September 30, 2013 | 0.55M |
| June 30, 2013 | 0.661M |
| March 31, 2013 | 0.201M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
8.97M
Minimum
Jun 2019
30.26M
Maximum
Jun 2022
19.26M
Average
20.67M
Median
Research and Development Expense (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 5.971M |
| Ardelyx Inc | 10.58M |
| Arcus Biosciences Inc | 109.00M |
| Arcutis Biotherapeutics Inc | 23.14M |
| SeaStar Medical Holding Corp | 1.075M |